- Published on
An analysis of how GLP-1 receptor agonists are transforming the treatment of obesity and diabetes, while posing new challenges for healthcare economics and corporate strategy.
MD/MBA candidate with a stint in management consulting, I'm on a mission to decode the complexities of our healthcare system. Curious about how hospitals tick, what drives pharma innovation, or how the latest legislation reshapes patient care? You're in the right place! Join me as I unpack these topics and more, sharing insights and sparking conversations along the way.